These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


400 related items for PubMed ID: 9167107

  • 1. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG.
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [Abstract] [Full Text] [Related]

  • 2. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M, Karjalainen J, Akerblom HK.
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [Abstract] [Full Text] [Related]

  • 3. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J, Seidel D, Schenker M, Ziegler AG.
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M.
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I, Hummel M, Ziegler AG.
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y, Kawasaki E, Abiru N, Ozaki M, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K.
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS, Colman PG, Harrison LC.
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.